Literature DB >> 15878714

Relaxations to oestrogen receptor subtype selective agonists in rat and mouse arteries.

Khalid Al Zubair1, Adibah Razak, Sotiria Bexis, James R Docherty.   

Abstract

It has been recently reported that the oestrogen receptor alpha agonist PPT (4,4',4"-(4-propyl-[1H]-pyrazole-1,3,5-triyl) tris-phenol) is more potent than the oestrogen receptor beta agonist DPN (2,3-bis(4-hydroxyphenyl)-propionitrile) at producing relaxations in rat mesenteric artery. We have investigated the relaxant actions of PPT and DPN in rat and mouse aorta and mesenteric artery. In rat aortic rings contracted with KCl (40 mM), the oestrogen receptor beta agonist DPN produced significantly greater relaxations than the oestrogen receptor alpha agonist PPT. In wild-type (WT) mouse aorta, the same result was found, but in WT mouse mesenteric artery, as in rat mesenteric artery, DPN was significantly less potent than PPT in females but had similar potency to PPT in males. Relaxations to DPN also occurred in aorta from nitric oxide synthase-3-knockout (NOS-3-KO) mice, and in denuded aorta from both mouse and rat. Hence, in the mouse mesenteric artery, as in the rat mesenteric artery, PPT is at least as potent as DPN at producing relaxations; however, DPN was much more potent than PPT in the rat and mouse aorta. Effects of oestrogen receptor subtype selective agonists are tissue dependent. In addition, actions are largely endothelium-independent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878714     DOI: 10.1016/j.ejphar.2005.03.006

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Ovarian wedge resection restores fertility in estrogen receptor beta knockout (ERbeta-/-) mice.

Authors:  José Inzunza; Andrea Morani; Guojun Cheng; Margaret Warner; Julius Hreinsson; Jan-Ake Gustafsson; Outi Hovatta
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

Review 2.  The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Vascul Pharmacol       Date:  2011-07-05       Impact factor: 5.773

3.  Human uterine and placental arteries exhibit tissue-specific acute responses to 17β-estradiol and estrogen-receptor-specific agonists.

Authors:  Jemma J Corcoran; Christopher Nicholson; Michèle Sweeney; Jayne C Charnock; Stephen C Robson; Melissa Westwood; Michael J Taggart
Journal:  Mol Hum Reprod       Date:  2013-12-19       Impact factor: 4.025

4.  Estrogenic vascular effects are diminished by chronological aging.

Authors:  Christopher J Nicholson; Michèle Sweeney; Stephen C Robson; Michael J Taggart
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

5.  Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway.

Authors:  Jun Ming Wang; Lifei Liu; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2007-10-25       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.